Binfeng Chen
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Systemic Lupus Erythematosus Research 5
-
- Influenza Virus Research Studies 5
- Inflammatory Myopathies and Dermatomyositis 2
- Co-authors
- Ailan Chen (1 shared paper)Wei‐jie Guan (1 shared paper)Yuanda Xu (1 shared paper)Caichen Li (1 shared paper)Ling Sang (1 shared paper)Jianxing He (1 shared paper)Shiyue Li (1 shared paper)Yimin Li (1 shared paper)
- Journals
- Clinical and Translational Medicine (2 papers)European Journal of Medicinal Chemistry (2 papers)Frontiers in Immunology (2 papers)Molecular Therapy (2 papers)Nature Communications (1 paper)
- Partner nations
- ChinaSouth KoreaJapan
In The Last Decade
Binfeng Chen
21 papers receiving 1.3k citations
Binfeng Chen's Hit Papers
Peers
Comparison fields: 5 of 102
- Infectious Diseases 808
- Critical Care and Intensive Care Medicine 22
- Modeling and Simulation 22
- Health Informatics 10
- Nephrology 35
Countries citing papers authored by Binfeng Chen
This map shows the geographic impact of Binfeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binfeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binfeng Chen more than expected).
Fields of papers citing papers by Binfeng Chen
This network shows the impact of papers produced by Binfeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binfeng Chen. The network helps show where Binfeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Binfeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19 Hit paper breakdown → | 2020 | 1020 |
| 2 | 2022 | 44 | |
| 3 | 2023 | 42 | |
| 4 | 2024 | 28 | |
| 5 | 2022 | 26 | |
| 6 | 2022 | 26 | |
| 7 | 2022 | 19 | |
| 8 | 2022 | 18 | |
| 9 | 2018 | 14 | |
| 10 | 2019 | 13 | |
| 11 | 2022 | 10 | |
| 12 | 2019 | 8 | |
| 13 | 2024 | 8 | |
| 14 | 2020 | 7 | |
| 15 | 2021 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2025 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2023 | 2 |
About Binfeng Chen
Binfeng Chen is a scholar working on Rheumatology, Epidemiology, Nephrology, Language and Linguistics and Water Science and Technology, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (5 papers), Systemic Lupus Erythematosus Research (5 papers), Adsorption and biosorption for pollutant removal (2 papers), Renal Diseases and Glomerulopathies (2 papers), Carbohydrate Chemistry and Synthesis (2 papers), Inflammatory Myopathies and Dermatomyositis (2 papers), EFL/ESL Teaching and Learning (2 papers) and Inflammatory Bowel Disease (2 papers). The work is most often cited by research in Infectious Diseases (808 citations), Critical Care and Intensive Care Medicine (22 citations), Modeling and Simulation (22 citations), Health Informatics (10 citations) and Nephrology (35 citations). Binfeng Chen has collaborated with scholars based in China, South Korea and Japan. Frequent co-authors include Ailan Chen, Wei‐jie Guan, Yuanda Xu, Caichen Li, Ling Sang, Jianxing He, Shiyue Li, Yimin Li, Jun Guo and Haiyan Guo. Their work appears in journals such as Clinical and Translational Medicine, European Journal of Medicinal Chemistry, Frontiers in Immunology, Molecular Therapy and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.